000 | 01635 a2200433 4500 | ||
---|---|---|---|
005 | 20250515173911.0 | ||
264 | 0 | _c20091202 | |
008 | 200912s 0 0 eng d | ||
022 | _a1439-4286 | ||
024 | 7 |
_a10.1055/s-0029-1224116 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aPapewalis, C | |
245 | 0 | 0 |
_aRole of the novel mTOR inhibitor RAD001 (everolimus) in anaplastic thyroid cancer. _h[electronic resource] |
260 |
_bHormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme _cOct 2009 |
||
300 |
_a752-6 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 |
_aCarcinoma _xdrug therapy |
650 | 0 | 4 | _aCell Line, Tumor |
650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 | _aEverolimus |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImmunosuppressive Agents _xpharmacology |
650 | 0 | 4 |
_aProliferating Cell Nuclear Antigen _xgenetics |
650 | 0 | 4 |
_aProtein Kinases _xgenetics |
650 | 0 | 4 |
_aRNA _xchemistry |
650 | 0 | 4 | _aReverse Transcriptase Polymerase Chain Reaction |
650 | 0 | 4 |
_aSirolimus _xanalogs & derivatives |
650 | 0 | 4 | _aTOR Serine-Threonine Kinases |
650 | 0 | 4 |
_aThyroid Neoplasms _xdrug therapy |
700 | 1 | _aWuttke, M | |
700 | 1 | _aSchinner, S | |
700 | 1 | _aWillenberg, H S | |
700 | 1 | _aBaran, A M | |
700 | 1 | _aScherbaum, W A | |
700 | 1 | _aSchott, M | |
773 | 0 |
_tHormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme _gvol. 41 _gno. 10 _gp. 752-6 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1055/s-0029-1224116 _zAvailable from publisher's website |
999 |
_c18933960 _d18933960 |